Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Barriers to early uptake of tetanus, diphtheria and acellular pertussis vaccine (Tdap) among adults-United States, 2005-2007.

Miller BL, Kretsinger K, Euler GL, Lu PJ, Ahmed F.

Vaccine. 2011 May 17;29(22):3850-6. doi: 10.1016/j.vaccine.2011.03.058. Epub 2011 Apr 1.

PMID:
21459173
2.

Tetanus and pertussis vaccination coverage among adults aged ≥ 18 years --- United States, 1999 and 2008.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2010 Oct 15;59(40):1302-6.

3.
4.

Predictors of tetanus-diphtheria- acellular pertussis vaccination among adults receiving tetanus vaccine in the United States: data from the 2008 national health interview survey.

Johns TL, Roetzheim R, Chen R.

J Prim Care Community Health. 2013 Apr 1;4(2):95-100. doi: 10.1177/2150131912455428. Epub 2012 Aug 1.

PMID:
23799715
5.

Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.

Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, Tiwari T, Cohn AC, Slade BA, Iskander JK, Mijalski CM, Brown KH, Murphy TV; Centers for Disease Control and Prevention; Advisory Committee on Immunization Practices; Healthcare Infection Control Practices Advisory Committee.

MMWR Recomm Rep. 2006 Dec 15;55(RR-17):1-37.

6.

Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP), 2012.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2012 Jun 29;61(25):468-70. Erratum in: MMWR Morb Mortal Wkly Rep. 2012 Jul 13;61(27):515.

7.

Impact of tetanus, diphtheria, and acellular pertussis (Tdap) vaccine use in wound management on health care costs and pertussis cases.

Talbird SE, Graham J, Mauskopf J, Masseria C, Krishnarajah G.

J Manag Care Spec Pharm. 2015 Jan;21(1):88-99, 99a-c.

8.

Tetanus, diphtheria and acellular pertussis (Tdap) vaccination among healthcare personnel-United States, 2011.

Lu PJ, Graitcer SB, O'Halloran A, Liang JL.

Vaccine. 2014 Jan 23;32(5):572-8. doi: 10.1016/j.vaccine.2013.11.077. Epub 2013 Dec 3.

PMID:
24308960
9.

Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.

America Academy of Pediatrics Commitee on Infectious Diseases.

Pediatrics. 2006 Mar;117(3):965-78. Epub 2005 Dec 28.

PMID:
16382131
10.

Notes from the field : use of tetanus, diphtheria, and pertussis vaccine (Tdap) in an Emergency Department - Arizona, 2009-2010.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2012 Jan 27;61(3):55-6.

11.

Noninfluenza vaccination coverage among adults - United States, 2012.

Williams WW, Lu PJ, O'Halloran A, Bridges CB, Pilishvili T, Hales CM, Markowitz LE; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Feb 7;63(5):95-102.

13.

Implementation of cocooning against pertussis in a high-risk population.

Healy CM, Rench MA, Baker CJ.

Clin Infect Dis. 2011 Jan 15;52(2):157-62. doi: 10.1093/cid/ciq001.

PMID:
21288837
14.

Use of mass Tdap vaccination to control an outbreak of pertussis in a high school--Cook County, Illinois, September 2006-January 2007.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2008 Jul 25;57(29):796-9.

15.

Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis.

Wei SC, Tatti K, Cushing K, Rosen J, Brown K, Cassiday P, Clark T, Olans R, Pawloski L, Martin M, Tondella ML, Martin SW.

Clin Infect Dis. 2010 Aug 1;51(3):315-21. doi: 10.1086/653938.

PMID:
20578875
16.

Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.

Zepp F, Knuf M, Habermehl P, Mannhardt-Laakmann W, Howe B, Friedland LR.

J Pediatr. 2006 Nov;149(5):603-610.

PMID:
17095328
18.
19.

Vaccination coverage among adolescents aged 13-17 years - United States, 2007.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2008 Oct 10;57(40):1100-3. Erratum in: MMWR Morb Mortal Wkly Rep. 2009 Jan 16;58(1):10.

20.

Universal tetanus, diphtheria, acellular pertussis (Tdap) vaccination of adults: What Canadian health care providers know and need to know.

MacDougall D, Halperin BA, MacKinnon-Cameron D, Li L, McNeil SA, Langley JM, Halperin SA.

Hum Vaccin Immunother. 2015;11(9):2167-79. doi: 10.1080/21645515.2015.1046662. Epub 2015 Jun 19.

Supplemental Content

Support Center